Herpes simplex virus and human papillomavirus infection in cervical disease in Argentine women

International Journal of Gynecological Pathology

Volumn 25, Issue 1, 2006, Pages 42-47

  Pérez, Luis Orlando ^a   Barbisan, Gisela ^a   Abba, Martín Carlos ^a   Laguens, Rubén Martín ^b   Dulout, Fernando Noel ^a   Golijow, Carlos Daniel ^a  

^a UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Cervical cancers; Herpes simplex virus; Human papillomavirus infection

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; CANCER GRADING; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; VIRUS INFECTION; WART VIRUS; GENETICS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY;

ADOLESCENT; ADULT; AGED; ARGENTINA; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; HERPES SIMPLEX; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; SIMPLEXVIRUS; UTERINE CERVICAL NEOPLASMS;

EID: 33644830560     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pgp.0000177996.30427.2b     Document Type: Article

References (36)

1. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base N° 5 version 2.0. Lyon: IARC Press, 2004.
2. Fundación FUNDONAR, Compendio de Registro de Cáncer de la Provincia de Buenos Aires, Periodo 1996-2000. Ministerio de Salud, Argentina, 2000.
3. zur Hausen H. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
4. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
5. Golijow CD, Abba MC, Mouron SA, et al. Chlamydia trachomatis and human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol 2005;96:181-6.
6. Vonka V, Kanka J, Hirsch I, et al. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment. Int J Cancer 1984;33:61-6.
7. Dürst M, Gissmann L, Ikenberg H, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983;80:3812-5.
8. Smith JS, Herrero R, Bosetti C, et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002;94:1604-13.
9. Munoz N, Kato I, Bosch FX, et al. Cervical cancer and herpes simplex virus type 2: Case-control studies in Spain and Colombia, with special reference to immunoglobulin-G subclasses. Int J Cancer 1995;60:438-42.
10. Lehtinen M, Koskela P, Jellum E, et al. Herpes simplex virus and risk of cervical cancer: A longitudinal, nested case-control study in the Nordic countries. Am J Epidemiol 2002;156:687-92.
11. Castle PE, Escoffery C, Schachter J, et al. Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis 2003;30:575-80.
12. Guibinga GH, Coutlee F, Kessous A, et al. Role of herpes simplex type 2 in genital cancers: review of the evidence. Arch STD HIV Res 1995;9:164-79.
13. Yamakawa Y, Forslund O, Chua KL, et al. Detection of the BC 24 transforming fragment of the herpes simplex virus type 2 (HSV-2) DNA in cervical carcinoma tissue by polymerase chain reaction (PCR). APMIS 1994;102:401-6.
14. Lulitanond V, Chantratita W, Thammaprasert K, et al. Detection of herpes simplex virus type 2 Bgl II N fragment in paraffin-embedded cervical tissue sections using nested polymerase chain reaction. Mol Cell Probes 1994;8:441-7.
15. Koffa M, Koumantakis E, Ergazaki M, et al. Association of herpes-virus infection with the development of genital cancer. Int J Cancer 1995;63:58-62.
16. Vecchione A, Cermele C, Giovagnoli MR, et al. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix. Gynecol Oncol 1994;55:343-8.
17. Baldauf JJ, Dreyfus M, Ritter J, et al. A PCR study on the coexistence of herpes simplex virus, cytomegalovirus and human papillomavirus DNAs in cervical neoplasia. Int J Gynecol Cancer 1996;6:389-95.
18. Tran-Thanh D, Provencher D, Koushik A, et al. Herpes simplex virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 2003;188:129-34.
19. Jackson DP, Hayden JD, Quirke P. Extraction of nucleic acid from fresh and archival material. In: McPherson MJ, Quirke P, Taylor GR, eds. PCR: a practical approach. New York: Oxford University Press, 1993:29-50.
20. Golijow CD, Abba M, Mouron SA, et al. Detection of c-erbB-2 gene amplification in cervical scrapes positives for HPV. Cancer Invest 2001;19:678-83.
21. Evander M, Edlund K, Bodun E, et al. Comparison of one-step and two-step polymerase chain reaction with degenerate general primers in a population-based studies of human papillomavirus infection in young Swedish women. J Clin Microbiol 1992;30:987-92.
22. de Roda Husman AM, Walboomers JMM, van den Brule AJC, et al. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
23. Strauss S, Jordens JZ, Desselberger U, et al. Single-tube real-time nested polymerase chain reaction for detecting human papillomavirus DNA. Diagn Mol Pathol 2000;9:151-7.
24. Remmerbach TW, Brinckmann UG, Hemprich A, et al. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 2004;30:302-8.
25. Abba MC, Mouron SA, Gomez MA, et al. Association of Human papillomavirus viral load with HPV-16 and high-grade intraepithelial lesion. Int J Gynecol Cancer 2003;13:154-8.
26. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995;171:857-63.
27. Abba MC, Golijow CD. Herpes simplex virus genotyping: multiple optional PCR-based RFLP systems and non-isotopic single-strand conformation polymorphism method. J Virol Methods 2004;118:73-6.
28. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis 2002;186:S3-28.
29. Weiss H. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 2004;11:24A-35A.
30. de Sanjose S, Munoz N, Bosch FX, et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994;56:358-63.
31. Boulos R, Ruff AJ, Nahmias A, et al. Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T lymphotropic virus type I infections. The Johns Hopkins University (JHU)/Centre pour le Developpement et la Sante (CDS) HIV Study Group. J Infect Dis 1992;166:418-20.
32. Lazcano-Ponce E, Smith JS, Munoz N, et al. High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women in Mexico City, Mexico: a population-based study. Sex Transm Dis 2001;28:270-6.
33. Smith JS, Herrero R, Munoz N, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-age women in Brazil and the Philippines. Sex Transm Dis 2001;28:187-94.
34. Oberle MW, Rosero-Bixby L, Lee FK, et al. Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica. Am J Trop Med Hyg 1989;41:224-9.
35. Hildesheim A, Mann V, Brinton LA, et al. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer 1991;49:335-40.
36. Galloway DA, McDougall JK. The oncogenic potential of herpes simplex viruses: evidence for a 'hit-and-run' mechanism. Nature 1983;302:21-4.